Fuji, Japan

Kaoru Yoshinari


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kaoru Yoshinari: Innovator in Biological Response Modifiers

Introduction

Kaoru Yoshinari is a prominent inventor based in Fuji, Japan. He has made significant contributions to the field of biological response modifiers, particularly in the context of leukemia treatment. His innovative work has led to the development of a unique proteinaceous biological response modifier that exhibits promising anti-tumor activity.

Latest Patents

Yoshinari holds a patent for a biological response modifier that has several noteworthy properties. This modifier has a molecular weight ranging from 35,000 to 65,000 and an isoelectric point between 5.0 and 6.1. It has been shown to induce human leukemia cells to differentiate into macrophage-like cells, which is crucial for potential therapeutic applications. The modifier is stable across a wide pH range and demonstrates significant resistance to inactivation by various enzymes, making it a robust candidate for further research and development.

Career Highlights

Kaoru Yoshinari serves as the Director-General of the Agency of Industrial Science and Technology. His leadership in this role has allowed him to influence advancements in industrial science and technology in Japan. His dedication to research and innovation has positioned him as a key figure in the scientific community.

Collaborations

Yoshinari has collaborated with notable colleagues such as Akio Mimura and Katsumi Yuasa. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the field of biological sciences.

Conclusion

Kaoru Yoshinari's contributions to the field of biological response modifiers highlight his role as an influential inventor. His patented work on a proteinaceous biological response modifier showcases his commitment to advancing medical science and improving treatment options for leukemia. His ongoing efforts continue to inspire innovation in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…